FredLublinMD

Neurology • New York, NY

Neuroimmunology/Multiple Sclerosis

Saunders Family Professor of Neurology, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Lublin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lublin's full profile

Already have an account?

Office
5 E 98th St
1st Floor
New York, NY 10029
Phone+1 212-241-6854

Fax+1 212-241-4460
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1975 - 1976
Zucker School of Medicine at Hofstra/NorthwellResidency, Neurology, 1974 - 1975
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1973 - 1974
Jacobi Medical Center/Albert Einstein College of MedicineInternship, Internal Medicine, 1972 - 1973
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1972

Certifications & Licensure

NJ State Medical License 2020 - 2025
NY State Medical License 1973 - 2025
PA State Medical License 1976 - 2024
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2003-2018
America's Top Doctors Castle Connolly, 2002-2018
New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2015
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx Start of enrollment: 2005 Jan 01
Completed
Phase 3
Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis Start of enrollment: 2002 Dec 01
Completed
Phase 2
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks Start of enrollment: 2003 Sep 01
Terminated
Phase 3
Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses Start of enrollment: 2013 Jul 01
Unknown status
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Worsening MS-A reappraisal of how we characterize the MS disease course.
Fred D Lublin> ;Multiple Sclerosis. 2023 Dec 1
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.
Marcus W Koch, Ester Moral, Luis Brieva, Jop Mostert, Eva Mm Strijbis, Jacynthe Comtois, Pavle Repovic, James D Bowen, Jerry S Wolinsky, Fred D Lublin, Gary Cutter> ;Multiple Sclerosis. 2023 Dec 1
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Alan J Thompson, Marcello Moccia, Maria Pia Amato, Peter A Calabresi, Marcia Finlayson, Annie Hawton, Fred D Lublin, Ruth Ann Marrie, Xavier Montalban, Michael Panzara...> ;Multiple Sclerosis. 2023 Oct 1
Polygenicity of Comorbid Depression in Multiple Sclerosis.
Kaarina Kowalec, Kathryn C Fitzgerald, Amber Salter, Casandra Dolovich, Arvid Harder, Charles N Bernstein, James Bolton, Gary R Cutter, Lesley A Graff, Sara Hägg, Caro...> ;Neurology. 2023 Aug 1
1 citations
MS becomes a treatable disease: 30 years later.
Fred D Lublin, Stephen C Krieger> ;Multiple Sclerosis. 2023 Jun 1
1 citations
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study.
Le H Hua, Amit Bar-Or, Stanley L Cohan, Fred D Lublin, Patricia K Coyle, Bruce Ac Cree, Xiangyi Meng, Wendy Su, Gina Mavrikis Cox, Robert J Fox> ;Multiple Sclerosis and Related Disorders. 2023 Jul 1
2 citations
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and ...
Jacqueline Nicholas, Fred Lublin, Sylvia Klineova, Joris Berwaerts, Robert Chinnapongse, Daniel Checketts, Sajida Javaid, Joshua R Steinerman> ;Multiple Sclerosis and Related Disorders. 2023 Jul 1
2 citations
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized Combi...
Gary Cutter, Richard A Rudick, Carl de Moor, Carol M Singh, Elizabeth Fisher, Thijs Koster, Fred D Lublin, Jerry S Wolinsky, Henry McFarland, Steven Jacobson, Maria L ...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2023 Apr 27
2 citations
The impact of relapse definition and measures of durability on MS clinical trial outcomes.
Sammita Satyanarayan, Gary Cutter, Stephen Krieger, Stacey Cofield, Jerry S Wolinsky, Fred Lublin> ;Multiple Sclerosis. 2023 Apr 1
6 citations
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
Jeffrey A Cohen, Fred D Lublin, Christoper Lock, Daniel Pelletier, Tanuja Chitnis, Munish Mehra, Yael Gothelf, Revital Aricha, Stacy Lindborg, Chaim Lebovits, Yossef L...> ;Multiple Sclerosis. 2023 Jan 1
6 citations
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan, Susan Filomena, Erin Staker, Johnstone Tcheou, Aaron Miller...> ;Multiple Sclerosis and Related Disorders. 2023 Feb 1
7 citations
Disability outcomes in early-stage African American and White people with multiple sclerosis.
Maria Petracca, Raffaele Palladino, Amgad Droby, Daniel Kurz, Nicole Graziano, Katherine Wang, Claire Riley, Jonathan Howard, Sylvia Klineova, Fred Lublin, Matilde Ing...> ;Multiple Sclerosis and Related Disorders. 2023 Jan 1
28 citations
How patients with multiple sclerosis acquire disability.
Fred D Lublin, Dieter A Häring, Habib Ganjgahi, Alex Ocampo, Farhad Hatami, Jelena Čuklina, Piet Aarden, Frank Dahlke, Douglas L Arnold, Heinz Wiendl, Tanuja Chitnis, ...> ;Brain. 2022 Sep 14
3 citations
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis.
Yinan Zhang, Stacey Cofield, Gary Cutter, Stephen Krieger, Jerry S Wolinsky, Fred Lublin> ;Neurology. Clinical Practice. 2022 Aug 1
10 citations
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis.
Sammita Satyanarayan, Neha Safi, Tali Sorets, Susan Filomena, Yinan Zhang, Sylvia Klineova, Michelle Fabian, Sam Horng, Stephanie Tankou, Aaron Miller, Stephen Krieger...> ;Multiple Sclerosis and Related Disorders. 2022 Jun 1
36 citations
Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
Achilles Ntranos, Hye-Jin Park, Maureen Wentling, Vladimir Tolstikov, Mario Amatruda, Benjamin Inbar, Seunghee Kim-Schulze, Carol Frazier, Judy Button, Michael A Kiebi...> ;Brain. 2022 Apr 18
1 citations
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosis.
Marcus W Koch, Jop Mostert, Pavle Repovic, James D Bowen, Jerry S Wolinsky, Fred D Lublin, Eva Strijbis, Gary Cutter> ;European Journal of Neurology. 2022 Apr 1
2 citations
The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing-Remitting Multiple sclerosis: A CombiRx Secondary Analysis.
Aliza Bitton Ben-Zacharia, Malvin N. Janal, Abraham A Brody, Jerry S. Wolinsky, Fred D. Lublin, Gary R. Cutter> ;Journal of Central Nervous System Disease. 2021 Nov 6
1 citations
Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial.
Maria Petracca, Gary Cutter, Sirio Cocozza, Leorah Freeman, John Kangarlu, Monica Margoni, Matteo Moro, Stephen Krieger, Mohamed-Mounir El Mendili, Amgad Droby, Jerry ...> ;European Journal of Neurology. 2021 Oct 25
13 citations
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses
Samantha Epstein, Seth N Levin, Kaho B. Onomichi, Christopher Langston, Anusha K. Yeshokumar, Michelle Fabian, Ilana Katz Sand, Sylvia Klineova, Fred D. Lublin, Kierst...> ;Multiple Sclerosis and Related Disorders. 2021 Aug 28
16 citations
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
Marcus W. Koch, Jop P. Mostert, Jerry S. Wolinsky, Fred D. Lublin, Bernard M. J. Uitdehaag, Gary Cutter> ;Neurology. 2021 Aug 25
15 citations
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis:
Giancarlo Comi, Yuval Dadon, Nissim Sasson, Joshua R. Steinerman, Volker Knappertz, Timothy Vollmer, Alexey Boyko, Patrick Vermersch, Tjalf Ziemssen, Xavier Montalban,...> ;Multiple Sclerosis. 2021 Aug 11
10 citations
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
Marcus W. Koch, Jop P. Mostert, Yinan Zhang, Jerry S. Wolinsky, Fred D. Lublin, Eva Strijbis, Gary Cutter> ;Neurology. 2021 Sep 28
9 citations
Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessments:
Lisa Glukhovsky, Daniel Kurz, Rachel Brandstadter, Victoria M. Leavitt, Stephen Krieger, Michelle Fabian, Ilana Katz Sand, Sylvia Klineova, Claire S Riley, Fred D. Lub...> ;Multiple Sclerosis. 2021 Jul 1
14 citations
Dietary factors and MRI metrics in early Multiple Sclerosis
I.B. Katz Sand, Kathryn C. Fitzgerald, Yian Gu, Rachel Brandstadter, Claire S Riley, Korhan Buyukturkoglu, Victoria M Leavitt, Stephen Krieger, Aaron Miller, Fred D. L...> ;Multiple Sclerosis and Related Disorders. 2021 May 19
Join now to see all

Press Mentions

Two Mount Sinai Experts Receive Honors from the National Multiple Sclerosis SocietySeptember 16th, 2021
MS Treatment Baby-Boom: Quadruplets!May 6th, 2021
Experts Clarify Concepts of MS States to Improve Patient Care, Clinical TrialsJune 15th, 2020
Join now to see all